Key result
Oral administration of recombinant Lactobacillus plantarum expressing VP1 provided robust protection against FMDV challenge, with up to 100% of vaccinated guinea pigs protected compared to 20% in the milk control group.
Why the study?
Does oral vaccination with recombinant Lactobacillus plantarum expressing VP1 improve immune response and protection against FMDV in guinea pigs?
Does oral vaccination with recombinant Lactobacillus plantarum expressing VP1 improve immune response and protection against FMDV in guinea pigs?
Answers are grounded in this paper and cite their sources.
Oral administration of recombinant Lactobacillus plantarum expressing VP1 induces mucosal and systemic immunity and protects guinea pigs against FMDV.
Mucosal vaccination is an effective strategy for generating antigen-specific immune responses against mucosal infections of foot-and-mouth disease virus (FMDV). In this study, Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs. Guinea pigs were orally vaccinated (three doses) with NC8-pSIP411, NC8-pSIP411-VP1, WCFS1-pSIP411, WCFS1-pSIP411-VP1 or milk. Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen-specific serum IgG, IgA, IgM, mucosal secretory IgA (sIgA) and neutralizing antibodies, and revealed stronger cell-mediated immune responses and enhanced protection against FMDV challenge compared with control groups. The recombinant pSIP411-VP1 effectively improved immunoprotection against FMDV in guinea pigs.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2015) studied Foot-and-Mouth Disease Virus (FMDV) infection (n=30). Recombinant Lactobacillus plantarum expressing VP1 (NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1) vs. Empty vector (NC8-pSIP411, WCFS1-pSIP411) or milk was evaluated on Protection against FMDV challenge (absence of secondary vesicles). Oral administration of recombinant Lactobacillus plantarum expressing VP1 provided robust protection against FMDV challenge, with up to 100% of vaccinated guinea pigs protected compared to 20% in the milk control group.
Synapse has enriched 10 related papers. Consider them for comparative context: